Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red blood cell alloimmunization in pregnancy.

Kenneth J Moise1

  • 1Division of Maternal-Fetal Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7516, USA. kmoisejr@med.unc.edu

Seminars in Hematology
|July 26, 2005
PubMed
Summary

Red blood cell alloimmunization in pregnancy persists despite Rhesus immune globulin (RhIG) use. Current management involves fetal surveillance via Doppler ultrasound and interventions like intrauterine transfusion, achieving high survival rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Free Fetal DNA Testing to Guide Early Intervention in the Management of the Kell Alloimmunized Pregnancy.

Prenatal diagnosis·2026
Same author

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

NEJM evidence·2026
Same author

The Ethics of Clinical Research on Diseases of the Fetus and Newborn: Balancing Benefit-Risk, Autonomy, and Maternal-Fetal Interests.

American journal of perinatology·2025
Same author

Comparison of Insertion Difficulties and Performance of Thoracoamniotic Shunts for Fetal Hydrothorax: Success and Failure Rates in Different Shunt Types for Fetal Hydrothorax.

Prenatal diagnosis·2025
Same author

A Clinical Practice Guideline for the Management of Pregnancy Alloimmunized to Red Blood Cell Antigens.

JAMA network open·2025
Same author

Biologics in red cell and platelet alloimmunizations: State of the science and future perspectives.

Best practice & research. Clinical obstetrics & gynaecology·2025

Area of Science:

  • Obstetrics and Gynecology
  • Immunology
  • Fetal Medicine

Background:

  • Red blood cell (RBC) alloimmunization in pregnancy remains a clinical challenge despite Rhesus immune globulin (RhIG) prophylaxis.
  • Administration gaps and sensitization to non-Rh(D) antigens contribute to ongoing cases.

Purpose of the Study:

  • To outline the current diagnostic and management strategies for alloimmunized pregnancies.
  • To highlight the effectiveness of existing interventions and future therapeutic directions.

Main Methods:

  • Maternal antibody titers are assessed to identify alloimmunization.
  • Fetal surveillance includes Doppler ultrasound of the middle cerebral artery (MCA) peak velocity.
  • Genetic testing via amniocentesis and invasive procedures like cordocentesis are employed for diagnosis and treatment.

Related Experiment Videos

Main Results:

  • Doppler ultrasound of MCA is used to detect fetal anemia when titers reach critical levels.
  • Intrauterine transfusion therapy is initiated for confirmed fetal anemia, leading to high perinatal survival rates.
  • Perinatal survival exceeding 85% with normal neurologic outcomes is now achievable.

Conclusions:

  • Despite challenges, current management protocols for RBC alloimmunization in pregnancy are effective.
  • Future research will focus on targeted immune modulation strategies for pregnant patients.